Involvement of central relaxin-3 signalling in sodium (salt) appetite

Experimental Physiology

Volumn 100, Issue 9, 2015, Pages 1064-1072

  Smith, Craig M ^a,b   Walker, Lesley L ^a   Chua, Berenice E ^a   Mckinley, Michael J ^a   Gundlach, Andrew L ^a,b   Denton, Derek A ^a,c,d   Lawrence, Andrew J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE RECEPTOR; RELAXIN 3; RELAXIN FAMILY PEPTIDE 3 RECEPTOR; UNCLASSIFIED DRUG; WATER; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; RELAXIN; RELAXIN-3 PROTEIN, MOUSE; SALPR PROTEIN, MOUSE; SALT INTAKE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRIVE; MOTIVATION; MOUSE; NONHUMAN; RANDOMIZATION; SIGNAL TRANSDUCTION; SODIUM APPETITE; SODIUM DEPLETION; WILD TYPE; ANIMAL; APPETITE; C57BL MOUSE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SALT INTAKE;

ANIMALS; APPETITE; AROUSAL; DRINKING BEHAVIOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RELAXIN; SIGNAL TRANSDUCTION; SODIUM; SODIUM CHLORIDE, DIETARY;

EID: 84940583161     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085349     Document Type: Article

References (52)

1. Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW & Borgland SL (2015). Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 172, 334-348.
2. Bathgate RAD, Lin F, Hanson NF, Otvos L Jr, Guidolin A, Giannakis C, Bastiras S, Layfield SL, Ferraro T, Ma S, Zhao C, Gundlach AL, Samuel CS, Tregear GW & Wade JD (2006). Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo. Biochemistry 45, 1043-1053.
3. Bathgate RAD, Oh MHY, Ling WJ, Kaas Q, Hossain MA, Gooley PR & Rosengren KJ (2013). Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3. Front Endocrinol 4, 13.
4. Bathgate RAD, Samuel CS, Burazin TCD, Layfield S, Claasz AA, Reytomas IG, Dawson NF, Zhao C, Bond C, Summers RJ, Parry LJ, Wade JD & Tregear GW (2002). Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 277, 1148-1157.
5. Blasiak A, Gundlach AL & Lewandowski MH (2010). Orexins increase nucleus incertus neuronal activity: implications for a possible reinforcing arousal drive. 7th Forum of European Neuroscience (FENS), Amsterdam, The Netherlands abstract 104.2 B73.
6. Cooper H, Bhattacharya B, Verma V, McCulloch AJ, Smellie WS & Heald AH (2007). Liquorice and soy sauce, a life-saving concoction in a patient with Addison's disease. Ann Clin Biochem 44, 397-399.
7. Crews EC & Rowland NE (2005). Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes. Am J Physiol Regul Integr Comp Physiol 288, R638-R644.
8. Daniels D & Fluharty SJ (2004). Salt appetite: a neurohormonal viewpoint. Physiol Behav 81, 319-337.
9. Denton DA (1983). The Hunger for Salt. An Anthropological, Physiological and Medical Analysis. Springer, Berlin.
10. Fu Y & Vallon V (2014). Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms. Nephron Physiol 128, 8-16.
11. Ganella DE, Callander GE, Ma S, Bye CR, Gundlach AL & Bathgate RA (2012). Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Gene Ther 20, 703-716.
12. Ganella DE, Ma S & Gundlach AL (2013). Relaxin-3/RXFP3 signaling and neuroendocrine function - a perspective on extrinsic hypothalamic control. Front Endocrinol 4, 128.
13. Geerling JC & Loewy AD (2008). Central regulation of sodium appetite. Exp Physiol 93, 177-209.
14. Goto M, Swanson LW & Canteras NS (2001). Connections of the nucleus incertus. J Comp Neurol 438, 86-122.
15. Haugaard-Kedström LM, Shabanpoor F, Hossain MA, Clark RJ, Ryan PJ, Craik DJ, Gundlach AL, Wade JD, Bathgate RA & Rosengren KJ (2011). Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3. J Am Chem Soc 133, 4965-4974.
16. Hentall ID & Gollapudi L (1995). The interpeduncular nucleus regulates nicotine's effects on free-field activity. Neuroreport 6, 2469-2472.
17. Hida T, Takahashi E, Shikata K, Hirohashi T, Sawai T, Seiki T, Tanaka H, Kawai T, Ito O, Arai T, Yokoi A, Hirakawa T, Ogura H, Nagasu T, Miyamoto N & Kuromitsu J (2006). Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. J Recept Signal Transduct Res 26, 147-158.
18. Hosken IT, Sutton SW, Smith CM & Gundlach AL (2015). Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal. Behav Brain Res 278, 167-175.
19. Hurley SW & Johnson AK (2015). The biopsychology of salt hunger and sodium deficiency. Pflugers Archiv 467, 445-456.
20. Johnson AK & Thunhorst RL (1997). The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18, 292-353.
21. Kauer JA & Malenka RC (2007). Synaptic plasticity and addiction. Nat Rev Neurosci 8, 844-858.
22. Koob GF & Bloom FE (1988). Cellular and molecular mechanisms of drug dependence. Science 242, 715-723.
23. Liedtke WB, McKinley MJ, Walker LL, Zhang H, Pfenning AR, Drago J, Hochendoner SJ, Hilton DL, Lawrence AJ & Denton DA (2011). Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. Proc Natl Acad Sci USA 108, 12509-12514.
24. Liu S & Borgland SL (2015). Regulation of the mesolimbic dopamine circuit by feeding peptides. Neuroscience 289, 19-42.
25. Lucas LR, Grillo CA & McEwen BS (2003). Involvement of mesolimbic structures in short-term sodium depletion: in situ hybridization and ligand-binding analyses. Neuroendocrinology 77, 406-415.
26. Lucas LR, Grillo CA & McEwen BS (2007). Salt appetite in sodium-depleted or sodium-replete conditions: possible role of opioid receptors. Neuroendocrinology 85, 139-147.
27. Ma S, Bonaventure P, Ferraro T, Shen PJ, Burazin TCD, Bathgate RAD, Liu C, Tregear GW, Sutton SW & Gundlach AL (2007). Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat. Neuroscience 144, 165-190.
28. Ma S & Gundlach AL (2015). Ascending control of arousal and motivation: role of nucleus incertus and its peptide neuromodulators in behavioural responses to stress. J Neuroendocrinol 27, 457-467.
29. Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, Wade JD, Sutton SW, Nuñez A & Gundlach AL (2009). Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 16, 730-742.
30. McGowan BM, Stanley SA, Smith KL, White NE, Connolly MM, Thompson EL, Gardiner JV, Murphy KG, Ghatei MA & Bloom SR (2005). Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146, 3295-3300.
31. McGowan BM, Stanley SA, White NE, Spangeus A, Patterson M, Thompson EL, Smith KL, Donovan J, Gardiner JV, Ghatei MA & Bloom SR (2007). Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab 292, E913-E919.
32. Morris MJ, Na ES & Johnson AK (2008). Salt craving: the psychobiology of pathogenic sodium intake. Physiol Behav 94, 709-721.
33. Na ES, Morris MJ & Johnson AK (2012). Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states. Physiol Behav 106, 164-170.
34. Odermatt A (2011). The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol 301, F919-F931.
35. Olucha-Bordonau FE, Teruel V, Barcia-González J, Ruiz-Torner A, Valverde-Navarro AA & Martínez-Soriano F (2003). Cytoarchitecture and efferent projections of the nucleus incertus of the rat. J Comp Neurol 464, 62-97.
36. Peyron C, Tighe DK, vanden Pol AN, deLecea L, Heller HC, Sutcliffe JG & Kilduff TS (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996-10015.
37. Ryan PJ, Kastman HE, Krstew EV, Rosengren KJ, Hossain MA, Churilov L, Wade JD, Gundlach AL & Lawrence AJ (2013). Relaxin-3/RXFP3 system regulates alcohol-seeking. Proc Natl Acad Sci USA 110, 20789-20794.
38. Ryan PJ, Krstew EV, Sarwar M, Gundlach AL & Lawrence AJ (2014). Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats. Drug Alcohol Depend 140, 8-16.
39. Saper CB, Fuller PM, Pedersen NP, Lu J & Scammell TE (2010). Sleep state switching. Neuron 68, 1023-1042.
40. Shabanpoor F, Akhter Hossain M, Ryan PJ, Belgi A, Layfield S, Kocan M, Zhang S, Samuel CS, Gundlach AL, Bathgate RA, Separovic F & Wade JD (2012). Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. J Med Chem 55, 1671-1681.
41. Sinnayah P, Burns P, Wade JD, Weisinger RS & McKinley MJ (1999). Water drinking in rats resulting from intravenous relaxin and its modification by other dipsogenic factors. Endocrinology 140, 5082-5086.
42. Smith CM, Chua BE, Zhang C, Walker AW, Haidar M, Hawkes D, Shabanpoor F, Hossain MA, Wade JD, Rosengren KJ & Gundlach AL (2014a). Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice. Behav Brain Res 268, 117-126.
43. Smith CM, Hosken IT, Sutton SW, Lawrence AJ & Gundlach AL (2012). Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 11, 94-104.
44. Smith CM, Ryan PJ, Hosken IT, Ma S & Gundlach AL (2011). Relaxin-3 systems in the brain-the first 10 years. J Chem Neuroanat 42, 262-275.
45. Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RA, Sutton SW & Gundlach AL (2010). Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518, 4016-4045.
46. Smith CM, Walker AW, Hosken IT, Chua BE, Zhang C, Haidar M & Gundlach AL (2014b). Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases? Front Pharmacol 5, 46.
47. Sunn N, Egli M, Burazin TC, Burns P, Colvill L, Davern P, Denton DA, Oldfield BJ, Weisinger RS, Rauch M, Schmid HA & McKinley MJ (2002). Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci USA 99, 1701-1706.
48. Sutton SW, Shelton J, Smith CM, Williams J, Yun S, Motley T, Kuei C, Bonaventure P, Gundlach AL, Liu C & Lovenberg T (2009). Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system. Ann N Y Acad Sci 1160, 242-249.
49. Tindell AJ, Smith KS, Pecina S, Berridge KC & Aldridge JW (2006). Ventral pallidum firing codes hedonic reward: when a bad taste turns good. J Neurophysiol 96, 2399-2409.
50. Walker AW, Smith CM, Chua BE, Krstew EV, Zhang C, Gundlach AL & Lawrence AJ (2015). Relaxin-3 receptor (RXFP3) signalling mediates stress-related alcohol preference in mice. PLoS One 10, e0122504.
51. Watanabe Y, Miyamoto Y, Matsuda T & Tanaka M (2010). Relaxin-3/INSL7 regulates the stress-response system in the rat hypothalamus. J Mol Neurosci 43, 169-174.
52. Wirtshafter D, Stratford TR & Pitzer MR (1993). Studies on the behavioral activation produced by stimulation of GABAB receptors in the median raphe nucleus. Behav Brain Res 59, 83-93.